Raised levels of cerebral cortex dolichols in Alzheimer's disease

Variation in social feeding behavior and interactions among Caenorhabditis nematodes.

bioRxiv : the preprint server for biology·2025

End of life decisions: attitudes of Finnish physicians.

Journal of medical ethics·2004

Increasing prevalence of multiple sclerosis in Finland.

Acta neurologica Scandinavica·2001

Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993.

Neuroepidemiology·2000

The cover-up of president Urho Kekkonen's dementia and its impact on the political life of Finland-a personal account.

European journal of neurology·1999

Golli-MBP gene in multiple sclerosis susceptibility.

Journal of neuroimmunology·1998

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

A Harmonized Method for the Analysis of 32 PFAS in Priority Food Matrices for Interagency Regulatory Analysis.

Journal of agricultural and food chemistry·2026

Assessment of a direct fluorescence-based cell-free DNA assay for evaluating the extent of metastatic dissemination: An exploratory study.

Biomedical reports·2026

Analytical Evaluation of Urinary CXCL10 as a Biomarker for Kidney Allograft Rejection.

The journal of applied laboratory medicine·2026

Association of esketamine with acute lung injury and macrophage polarization-related markers after ATAAD surgery.

BMC surgery·2026

The Prague 2025 consensus checklist for reporting indirect outcome studies of Model 1b analytical performance specifications.

Clinical chemistry and laboratory medicine·2026

Study of the Extraction Process, Chemical Composition, and Biological Activities of Total Flavonoids from Vine Tea Leaves.

Molecules (Basel, Switzerland)·2026

Related Experiment Videos

Raised levels of cerebral cortex dolichols in Alzheimer's disease

Related Concept Videos

Variation in social feeding behavior and interactions among Caenorhabditis nematodes.

End of life decisions: attitudes of Finnish physicians.

Increasing prevalence of multiple sclerosis in Finland.

Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993.

The cover-up of president Urho Kekkonen's dementia and its impact on the political life of Finland-a personal account.

Golli-MBP gene in multiple sclerosis susceptibility.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

A Harmonized Method for the Analysis of 32 PFAS in Priority Food Matrices for Interagency Regulatory Analysis.

Assessment of a direct fluorescence-based cell-free DNA assay for evaluating the extent of metastatic dissemination: An exploratory study.

Analytical Evaluation of Urinary CXCL10 as a Biomarker for Kidney Allograft Rejection.

Association of esketamine with acute lung injury and macrophage polarization-related markers after ATAAD surgery.

The Prague 2025 consensus checklist for reporting indirect outcome studies of Model 1b analytical performance specifications.

Study of the Extraction Process, Chemical Composition, and Biological Activities of Total Flavonoids from Vine Tea Leaves.

Related Experiment Videos

Raised levels of cerebral cortex dolichols in Alzheimer's disease

Related Concept Videos

Related Articles